Epidemiologic studies, warts and all, are our best chance

Epidemiology

Volumn 22, Issue 5, 2011, Pages 636-637

  Hernán, Miguel A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DATA BASE; EPIDEMIOLOGICAL DATA; FOOD AND DRUG ADMINISTRATION; HEALTH CARE POLICY; HUMAN; MEDICAL RESEARCH; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NOTE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS;

COMPARATIVE EFFECTIVENESS RESEARCH; CONFIDENTIALITY; DRUG AND NARCOTIC CONTROL; EMPIRICAL RESEARCH; EPIDEMIOLOGIC METHODS; INFORMATION DISSEMINATION; NATIONAL INSTITUTES OF HEALTH (U.S.); OBSERVATION; PHARMACOEPIDEMIOLOGY; PRODUCT SURVEILLANCE, POSTMARKETING; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 80051516683     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0b013e318228cccb     Document Type: Note

References (4)

1. Hamburg M. The growing role of epidemiology in drug safety regulation. Epidemiology. 2011;22:622-624.
2. Lauer MS, Hodes R. Epidemiology, comparative effectiveness research, and the National Institutes of Health: forces of health. Epidemiology. 2011;22:625-628.
3. Madigan D, Ryan P. What can we really learn from observational studies? The need for empirical assessment of methodology for active drug safety surveillance and comparative effectiveness research. Epidemiology. 2011;22:629-631.
4. Reiter JP, Kinney SK. Sharing confidential data for research purposes: a primer. Epidemiology. 2011;22:632-635.